Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB1 | P46663 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 10/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2816054 | 0.83 | BDKRB1 (0.53) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL484505 | 0.83 | BDKRB1 (0.53) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2818672 | 0.79 | BDKRB1 (0.59) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2818774 | 0.77 | ITGB3 (0.44) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2817752 | 0.77 | ITGB3 (0.44) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2817512 | 0.74 | ITGB3 (0.42) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2818144 | 0.74 | ITGB3 (0.42) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2819707 | 0.72 | ITGB3 (0.44) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2817274 | 0.72 | ITGB3 (0.44) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 | |
| SCHEMBL2815693 | 0.72 | CYP2C9 (0.47) | BDKRB1ITGB3ITGA2BCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | BDKRB1 1/4885ITGB3 3292/4885ITGA2B 3190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.